https://bureaucracy.news/2026/11/08/the-red-tape-roundup-november-9-2026/Bureaucracy Timesen2026-11-08T16:00:00+00:00The Red Tape Roundup — November 9, 2026Alaska, FOIA, GAO, DOE, Inspector General, PHMSA, Government Oversight, government accountability, FDA, Millennium Challenge Corporation, LNG, Newsletter, Red Tape Rounduphttps://bureaucracy.news/wp-content/uploads/2026/09/bureaucracy-times-6aaedf7485127.png?w=150https://bureaucracy.news/2026/11/07/the-one-honest-guarantee-ginnie-mae/Bureaucracy Timesen2026-11-07T13:00:00+00:00The One Honest Guarantee in the Series, Sitting on Top of the Least Examined RiskFinancial Stability, GAO, government corporations, mortgage market, housing finance, HUD, Ginnie Mae, Nonbank Mortgage Servicershttps://bureaucracy.news/wp-content/uploads/2026/09/bureaucracy-times-6aac97d33fa40.png?w=150https://bureaucracy.news/2026/11/06/fdas-new-prescription-drug-app-guidance-confronts-a-familiar-question-where-is-the-clinical-evidence/Bureaucracy Timesen2026-11-06T21:00:00+00:00FDA’s New Prescription Drug App Guidance Confronts a Familiar Question: Where Is the Clinical Evidence?FDA, digital therapeutics, drug labeling, prescription apps, clinical evidence, Digihaler, Abilify MyCite, pharmaceutical regulationhttps://bureaucracy.news/wp-content/uploads/2026/10/bureaucracy-times-6ae4ac6bd218e.png?w=150